ANTI-CD96 ANTIBODIES AND METHODS OF USE THEREOF
., human CD96) and antagonize CD96 function. Also provided are pharmaceutical compositions comprising these antibodies, nucleic acids encoding these antibodies, expression vectors and host cells for making these antibodies, and methods of treating a subject using these antibodies. La presente descri...
Saved in:
Main Authors | , , , , , |
---|---|
Format | Patent |
Language | English Spanish |
Published |
24.06.2022
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | ., human CD96) and antagonize CD96 function. Also provided are pharmaceutical compositions comprising these antibodies, nucleic acids encoding these antibodies, expression vectors and host cells for making these antibodies, and methods of treating a subject using these antibodies.
La presente descripción proporciona anticuerpos que se unen específicamente a CD96 (p. ej., CD96 humano) y antagonizan la función de CD96. También se proporcionan composiciones farmacéuticas que comprenden estos anticuerpos, ácidos nucleicos que codifican estos anticuerpos, vectores de expresión y células huésped para fabricar estos anticuerpos, y métodos para tratar a un sujeto mediante el uso de estos anticuerpos. |
---|---|
Bibliography: | Application Number: CR20220076 |